🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the efficacy of combined afatinib and prednisone in previously...
Status
Active Not Recruiting
Location
UT Southwestern Medical Center
Start Date
2021-08-04
Trial ID
NCT04497584
Treatments Being Tested
Trial Objectives: The objective is to investigate the efficacy and safety ...
Status
Terminated
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2012-12
Trial ID
NCT01732640
Treatments Being Tested
The investigators are doing this research program to find out if the invest...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-05-29
Trial ID
NCT02274012
Treatments Being Tested
In general, for patients with stage I or II disease, surgery provides the b...
Status
Completed
Location
Shanghai Pulmonary Hospital
Start Date
2020-07-26
Trial ID
NCT04201756
Treatments Being Tested
To monitor the safety profile and efficacy of GIOTRIF® (afatinib dimaleate,...
Status
Completed
Location
Multiple Locations
Start Date
2014-10-31
Trial ID
NCT02285361
Treatments Being Tested
The purpose of this study is to investigate the control of disease in pretr...
Status
Completed
Location
Universitätsklinikum Köln
Start Date
2015-09-16
Trial ID
NCT02369484
Treatments Being Tested
This is a phase 2 trial investigating the effect and safety of afatinib in ...
Status
Unknown
Location
Peking University Cancer Hospital and Institute
Start Date
2019-04-28
Trial ID
NCT03940976
Treatments Being Tested
The purpose of this study is to evaluate the feasibility, efficacy and safe...
Status
Recruiting
Location
Renji hospital, Shanghai Jiaotong University School of Medicine
Start Date
2020-06-01
Trial ID
NCT04183712
Treatments Being Tested
This study sets out to determine the maximum tolerated dose (MTD) of afatin...
Status
Unknown
Location
Ludwig-Maximilians - University of Munich
Start Date
2016-09
Trial ID
NCT02975141
Treatments Being Tested
The objective of the Phase I step is to estimate the MTD at a dose level up...
Status
Completed
Location
1200.33.010 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00711594
Treatments Being Tested